已核实 DOI PubMed 相关产品: 6

De Novo Biosynthesis of Dihydroquercetin in Saccharomyces cerevisiae

Journal 2024 · IF 5.7 · 发表于 2024 年 8 月 24 日
作者: Hongbiao Li,Shuai Zhang,Zilong Dong,Xiaoyu Shan,Jingwen Zhou,Weizhu Zeng
阅读全文 在 PubMed 查看

摘要

Dihydroquercetin is a vital flavonoid compound with a wide range of physiological activities. However, factors, such as metabolic regulation, limit the heterologous synthesis of dihydroquercetin in microorganisms. In this study, flavanone 3-hydroxylase (F3H) and flavanone 3′-hydroxylase (F3′H) were screened from different plants, and their co-expression in Saccharomyces cerevisiae was optimized. Promoter engineering and redox partner engineering were used to optimize the corresponding expression of genes involved in the dihydroquercetin synthesis pathway. Dihydroquercetin production was further improved through multicopy integration pathway genes and systems metabolic engineering. By increasing NADPH and α-ketoglutarate supply, the catalytic efficiency of F3’H and F3H was improved, thereby effectively increasing dihydroquercetin production (235.1 mg/L). Finally, 873.1 mg/L dihydroquercetin titer was obtained by fed-batch fermentation in a 5-L bioreactor, which is the highest dihydroquercetin production achieved through de novo microbial synthesis. These results established a pivotal groundwork for flavonoids synthesis.

本研究中使用的阿拉丁产品

6 款产品在本文中被引用